Clin2
NCT05752149Possibly a fitRecruiting

Fluorescent-guided surgery for throat cancer patients

Squamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Hypopharynx

Part of Cancer clinical trials.

This study tests a special dye/light method during surgery for laryngeal and hypopharyngeal squamous cell cancer. The goal is to see if it’s safe and practical to help surgeons find the tumor more clearly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
27 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have confirmed squamous cell cancer in the larynx or hypopharynx from a biopsy
  • You are 18 years or older, and you can sign consent for the study
  • You can read and understand Dutch well enough to complete the consent form
  • You cannot be pregnant or breastfeeding
  • Your kidneys must work well (eGFR 60 or higher, not on kidney-risk medicines you can’t stop)
  • You should not have certain heart rhythm/strength and blood test issues (QTc under 500, and blood/organ tests not too abnormal)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05676788Not yet recruiting
Using a dye to guide precise lung surgery

This trial tests a special imaging technique that uses a harmless dye to help surgeons see the exact boundary between healthy and diseased lung tissue during surgery to remove a small part of the lung. This could help make the surgery more precise and potentially preserve more healthy lung.

Großhansdorf
NCT07650656Recruiting· Phase 2
Fluorescence-Guided Surgery to Improve Sarcoma Tumor Removal

This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.

Duarte, California
NCT07295275Recruiting
Fluorescence-guided surgery for liver cancer

This trial tests a new way to remove liver cancer during surgery. A special dye called ICG is injected into the artery leading to the liver, which makes the tumor glow under a special camera, helping the surgeon remove just the right area. This study checks if this technique is both safe and effective for people with a common type of liver cancer (hepatocellular carcinoma).

Beijing, Beijing Municipality
NCT06788548Recruiting
Fluorescence-Guided Surgery for Early Stomach Cancer

This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.

Beijing, Beijing Municipality
NCT05730595Not yet recruiting
Fluorescent dye guidance for rectal and sigmoid colon surgery

This trial tests whether using a special fluorescent dye during laparoscopic surgery helps surgeons better see and remove rectal or sigmoid colon cancer. The goal is to see if this technique makes the surgery more precise and possibly improves outcomes.

Hefei, Anhui
NCT05978882Not yet recruiting
Fluorescent-guided surgery for early stomach cancer

This trial tests a new way to find and remove early stomach cancer using a fluorescent dye that makes the cancer glow during surgery. It may help doctors be more precise and preserve more of your stomach.

Busan, Gijang-gun

Hear when a new Squamous Cell Carcinoma of the Larynx trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.